What to Expect During a Clinical Trial — A Patient Guide
Joining a clinical trial can feel overwhelming when you do not know what to expect. This guide walks you through each stage of participation so you can prepare for the process and feel confident in your decision.
Screening and Eligibility
After you express interest in a trial, the first step is screening. The research team will review your medical history, run blood tests, imaging, or other assessments to determine whether you meet the trial eligibility criteria. This process can take a few days to a few weeks.
Not everyone who applies to a trial is accepted. Eligibility criteria are specific — they may require a certain diagnosis, age range, prior treatment history, or health status. If you do not qualify for one trial, the team may suggest alternatives. Being screened and not accepted is common and does not reflect on you.
Informed Consent
If you pass screening, you will be asked to review and sign an informed consent document. This is not a contract — it is a detailed explanation of the trial including its purpose, procedures, risks, benefits, alternatives, and your rights. Take your time reading it. Ask questions. Bring a family member or friend if it helps.
Signing informed consent means you understand what the trial involves and agree to participate. It does not mean you cannot change your mind later. You can withdraw at any time.
During the Trial
Once enrolled, you follow the study protocol. This may include taking a medication, undergoing procedures, attending regular study visits, and completing questionnaires. The frequency of visits depends on the trial — some require weekly visits, others are monthly or quarterly.
The research team monitors your health throughout. You will have a point of contact for questions or concerns. If you experience side effects, report them immediately — the team is trained to manage them. Your safety is the top priority.
Completing the Trial and Follow-Up
When the treatment phase ends, there is usually a follow-up period where the research team continues to monitor your health. This helps them understand long-term effects of the treatment. Follow-up may involve clinic visits, phone calls, or questionnaires.
After the trial is complete, you will be informed of the overall results when they become available. In some cases, you may be offered continued access to the experimental treatment if it proves effective. Ask the research team about post-trial options before enrolling.
Frequently Asked Questions
How many visits will I need to make?
Visit frequency varies by trial. Some require weekly visits for a few months; others are monthly over a year or more. The trial listing and informed consent document will specify the expected schedule. Ask the research team for a calendar of visits before committing.
Will I know if I am getting the real treatment or a placebo?
In blinded trials, you will not know which group you are in until the study ends. This is done to prevent bias in the results. The study team will explain the trial design during informed consent. Not all trials use placebos — many compare the new treatment against an existing standard treatment.
What if I want to stop during the trial?
You can stop at any time. Your decision to withdraw will not affect your access to standard medical care. The research team will ask you to come in for a final assessment to ensure your health is stable, but participation is always voluntary.
Are my medical records kept private?
Yes. Clinical trial data is subject to strict privacy regulations (HIPAA in the US, Privacy Act in Australia). Your personal information is coded and anonymised in study reports. Only authorised research staff have access to your identifiable information.